AGYS vs TECH · P/E 137, rev $275.6M vs P/E 65, rev $1.22B
Agilysys Inc (AGYS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Agilysys Inc (AGYS) is a software - application company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AGYS revenue for 2025-03-31 was $275.6M. Net income was $23.2M. Revenue was up 16.1% from 2024-03-31 to 2025-03-31. AGYS currently screens at market cap $3.14B and trailing P/E 136.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AGYS currently screens at market cap $3.14B and trailing P/E 136.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AGYS and TECH stock pages for the full models.
Not investment advice.